Tramazolin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Topical sympathomimetic, vasoconstrictive.

IndicationThis section has been translated automatically.

Swelling of the mucous membranes in allergic rhinitis and allergic conjunctivitis.

Standard concentrationThis section has been translated automatically.

  • 0.12% as a nasal drop or spray, spray into each nostril as required
  • 0.05% in eye drops 2-3 times/day in the conjunctival sac

Remember! Limit the application time to a maximum of 14 days!

Undesirable effectsThis section has been translated automatically.

With prolonged or frequent use, occasional burning of the nasal mucosa after application, dry nasal mucosa, rhinitis sicca or sneezing. Overdosage rarely leads to tachycardia, increase in blood pressure and hyperhidrosis. Very seldom restlessness up to insomnia, tiredness or headaches. Occasionally nausea or dizziness.

PreparationsThis section has been translated automatically.

Rhinospray

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer